AtriCure, Inc. Reports Q2 2026 Financial Results

What Happened
AtriCure, Inc. announced its financial results for the second quarter ended June 30, 2026 via a press release dated July 23, 2026. The company filed an Item 2.02 Form 8-K furnishing that press release (Exhibit 99.1) and said it will discuss the quarterly results on a conference call the same day, July 23, 2026 at 4:30 p.m. Eastern Time. The filing is signed by CFO Angela L. Wirick.

Key Details

• Quarter reported: Q2 2026 (period ended June 30, 2026).
• Press release filed as Exhibit 99.1 to the Form 8-K (dated July 23, 2026).
• Conference call: July 23, 2026 at 4:30 p.m. Eastern Time to discuss the results.
• Form 8-K signed by Angela L. Wirick, Chief Financial Officer.

Why It Matters
This filing signals AtriCure is publicly releasing its quarterly earnings and hosting a management call to discuss results — key sources for investors to learn about revenue, earnings, trends, and any guidance updates. Retail investors should review the furnished press release (Exhibit 99.1) and consider listening to the conference call for the company’s details on quarterly performance.